Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.49 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.42 |
| ▸ | HSP90AB1 | P08238 | 2/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | G6PD | P11413 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | AMD1 | P17707 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15870556 | 0.92 | MEN1 (0.44) | MEN1KMT2ACYP1A2CYP2C19LMNA | |
| SCHEMBL15868231 | 0.90 | MEN1 (0.46) | MEN1KMT2ACYP1A2CYP2C19LMNA | |
| SCHEMBL10729628 | 0.90 | MEN1 (0.46) | MEN1KMT2ACYP1A2CYP2C19LMNA | |
| SCHEMBL28867958 | 0.88 | MEN1 (0.57) | MEN1KMT2ACYP1A2CYP2C19LMNA | |
| SCHEMBL10362552 | 0.83 | MEN1 (0.56) | MEN1KMT2ACYP1A2CYP2C19LMNA | |
| SCHEMBL31079497 | 0.82 | MEN1 (0.40) | MEN1KMT2ACYP1A2CYP2C19LMNA | |
| SCHEMBL7452356 | 0.82 | MEN1 (0.40) | MEN1KMT2ACYP1A2CYP2C19LMNA | |
| SCHEMBL28230170 | 0.79 | KDM4E (0.41) | MEN1KMT2ACYP1A2CYP2C19LMNA | |
| SCHEMBL13728339 | 0.78 | ADORA2A (0.53) | MEN1KMT2ALMNATSHRALDH1A1 | |
| SCHEMBL25012029 | 0.77 | MEN1 (0.49) | MEN1KMT2ACYP1A2CYP2C19LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108970425-A | A kind of high-salt wastewater processing polymer film and preparation method thereof | 师帅帅 | 2018-12-11 | — | — | CN | claimed |
| CN-108034323-A | A kind of environment-friendly interior wall coating and preparation method thereof | 山东冬瑞高新技术开发有限公司 | 2018-05-15 | — | — | CN | claimed |
| CN-108970425-A | A kind of high-salt wastewater processing polymer film and preparation method thereof | 师帅帅 | 2018-12-11 | — | — | CN | disclosed |
| CN-108365038-A | A kind of solar cell backboard film and preparation method thereof | 湖南辰砾新材料有限公司 | 2018-08-03 | — | — | CN | disclosed |
| US-20140194429-A1 | COMPOSITIONS FOR TREATMENT OF CANCER | NOVARX CORPORATION | 2014-07-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140194429-A1 | COMPOSITIONS FOR TREATMENT OF CANCER | TP53, MCL1, CD44 | MEN1 3366/4885KMT2A 3142/4885CYP1A2 2968/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.